Schedule 13G ownership disclosure
Alto Neuroscience Inc
Common Stock, $0.0001 par value per share · CUSIP: 02157Q109
Event date: 2025-01-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- K2 HealthVentures Equity Trust LLC
Shares: 1,617,855 · Class: 5.6%
- Parag Shah
Shares: 1,617,855 · Class: 5.6%
- Anup Arora
Shares: 1,617,855 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905148-25-001714
- Form type
- SCHEDULE 13G
- Filer
- Alto Neuroscience, Inc.
- CIK
- CIK 1999480
- Filed
- May 15, 2025
- Reporting period
- Jan 13, 2025
- Description
- Schedule 13G beneficial ownership